Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Cardiology/Vascular Diseases | Endocrinology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Novartis
Approval Status: Approved September 1997
Treatment Area: coronary atherosclerosis
Lescol has been approved for a new indication--a treatment to
decrease the progression of coronary atherosclerosis in patients
with coronary heart disease undergoing treatment programs to lower
lipoprotein cholesterol. Lescol was originally approved in 1994 for
patients with primary hypercholesterolemia.
